{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:32:21Z","timestamp":1790299941483,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1213\/ane.0b013e3181ad63b4","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:16:20Z","timestamp":1253070980000},"page":"1070-1072","source":"Crossref","is-referenced-by-count":20,"title":["Malignant Hyperthermia-Like Syndrome and Carnitine Palmitoyltransferase II Deficiency with Heterozygous R503C Mutation"],"prefix":"10.1213","volume":"109","author":[{"given":"Kirk J.","family":"Hogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgirene D.","family":"Vladutiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210902","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005344-200007000-00002","article-title":"Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum.","volume":"36","author":"Yamada","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R2-14-20210902","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-3495(93)81101-9","article-title":"Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by palmitoyl carnitine.","volume":"65","author":"El-Hayek","year":"1993","journal-title":"Biophys J"},{"key":"R3-14-20210902","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1113\/jphysiol.1994.sp020275","article-title":"Effects of palmitoyl carnitine and related metabolites on the avian Ca2+-ATPase and the Ca2+ release channel.","volume":"479","author":"Dumonteil","year":"1994","journal-title":"J Physiol"},{"key":"R4-14-20210902","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/bj3250423","article-title":"Fatty acyl-CoA-acyl-CoA-binding protein complexes activate the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum.","volume":"325","author":"Fulceri","year":"1997","journal-title":"Biochem J"},{"key":"R5-14-20210902","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/mgme.2000.3009","article-title":"A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.","volume":"70","author":"Vladutiu","year":"2000","journal-title":"Mol Genet Metab"},{"key":"R6-14-20210902","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archotol.1986.03780050088017","article-title":"Markedly delayed postoperative malignant hyperthermia.","volume":"112","author":"Souliere","year":"1986","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R7-14-20210902","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bja\/82.6.945","article-title":"Suspected recurrence of malignant hyperthermia after post-extubation shivering in intensive care unit, 18 h after tonsillectomy.","volume":"82","author":"Short","year":"1999","journal-title":"Br J Anaesth"},{"key":"R8-14-20210902","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymgme.2008.05.002","article-title":"CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.","volume":"94","author":"Isackson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R9-14-20210902","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10545-007-0536-8","article-title":"Severe infantile type of carnitine palmitoyltransferase II (CPT II) deficiency due to homozygous R503C mutation.","volume":"30","author":"Spiegel","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"R10-14-20210902","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.880160509","article-title":"Carnitine palmitoyltransferase deficiency in malignant hyperthermia.","volume":"16","author":"Vladutiu","year":"1993","journal-title":"Muscle Nerve"},{"key":"R11-14-20210902","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nmd.2008.03.007","article-title":"No carnitine palmitoyltransferase deficiency in skeletal muscle in 18 malignant hyperthermia susceptible individuals.","volume":"18","author":"Wieser","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"R12-14-20210902","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies.","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"R13-14-20210902","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/1097-4598(200008)23:8<1157::AID-MUS1>3.0.CO;2-O","article-title":"Complex phenotypes in metabolic diseases.","volume":"23","author":"Vladutiu","year":"2000","journal-title":"Muscle Nerve"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181ad63b4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:12:58Z","timestamp":1786111978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200910000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181ad63b4","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}